(Q33913086)

English

Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Nikolaus Kohles

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dorothea Nagel

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dietrich Jüngst

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Jürgen Durner

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Petra Stieber

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Stefan Holdenrieder

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

26 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

202

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-11-202

0 references

Percutaneous image-guided therapy of intra-abdominal malignancy: imaging evaluation of treatment response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118895

5 July 2018

Using extracellular biomarkers for monitoring efficacy of therapeutics in cancer patients: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118895

5 July 2018

Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118895

5 July 2018

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118895

5 July 2018

Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants--initial experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118895

5 July 2018

Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118895

5 July 2018

Chemoembolization for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118895

5 July 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118895

5 July 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118895

5 July 2018

Estimating the world cancer burden: Globocan 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118895

5 July 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118895

5 July 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118895

5 July 2018

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118895

5 July 2018

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118895

5 July 2018

Hepatocellular carcinoma in southern Germany: epidemiological and clinicopathological characteristics and risk factors

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-202

21 January 2018

Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-202

21 January 2018

Diagnosis and Treatment of Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-202

21 January 2018

The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-202

21 January 2018

Nucleosomes in serum as a marker for cell death

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-202

21 January 2018

Dysregulation of apoptosis in hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-202

21 January 2018

Nucleosomes in pancreatic cancer patients during radiochemotherapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-202

21 January 2018

Treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-202

21 January 2018

Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21615953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21615953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical use of circulating nucleosomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21615953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21615953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/21615953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21615953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21615953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC

1 reference

https://pubmed.ncbi.nlm.nih.gov/21615953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nucleosomes in colorectal cancer patients during radiochemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21615953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-11-202

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33913086&oldid=1594636522"